4D Molecular Therapeutics, Inc. (FDMT): Depreciation & Amortization
$4.69M
Year ended 2025-12-31
$5.03M
Trailing 12 months to 2026-06-30
+25.0%
3-year compound annual growth
+26.6%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.69M | +0.9% | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | $4.65M | +10.7% | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | $4.20M | +74.9% | 2025-02-28, From 2023-01-01 |
| 2022-12-31 | $2.40M | +57.8% | 2024-02-29, From 2022-01-01 |
| 2021-12-31 | $1.52M | +5.5% | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $1.44M | +43.7% | 2022-03-28, From 2020-01-01 |
| 2019-12-31 | $1.00M | n/a | 2021-03-25, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $4.69M | +0.9% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $12.54M | -2.2% |
| Autolus Therapeutics plc (AUTL) | 2025-12-31 | $8.30M | +9.8% |
| Recursion Pharmaceuticals, Inc. (RXRX) | 2025-12-31 | $83.70M | +129.4% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $7.32M | +1.5% |
| Vir Biotechnology, Inc. (VIR) | 2025-12-31 | $11.68M | -19.8% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $15.53M | -11.6% |
| Agenus Inc (AGEN) | 2025-12-31 | $10.00M | -25.1% |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $2.12M | -58.1% |
Compare FDMT, MGTX, AUTL, RXRX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗